June 2019

On the Horizon - upcoming first generic launches*

TARGET DATE

BRAND NAME

GENERIC NAME

COMMON USE

 2017 U.S. BRAND SALES 

2H2019

LYRICA (capsules)

Pregabalin

Seizures, neuropathic pain

$5,465M

2H2019

ULORIC

Febuxostat

Gout

$578M

2H2019

APRISO

Mesalamine

Inflammatory Bowel Disease (IBD)

$312M

2H2019

EMEND (injection) (150 mg)

Fosaprepitant Dimeglumine

Nausea or vomiting of chemotherapy

$328M

2H2019

EVZIO

Naloxone Hydrochloride

Substance dependence or overdose

$57M

2H2019

ROZEREM

Ramelteon

Insomnia

$93M

2H2019

TRAVATAN Z

Travoprost

Glaucoma 

$544M

2020

ATRIPLA

Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate

HIV

$1,273M

2020

TRUVADA (200 mg/300 mg)

Emtricitabine; Tenofovir Disoproxil Fumarate

HIV

$3,151M

2020

KUVAN (tablet)

Sapropterin Dihydrochloride

Phenylketonuria

$25M

2020

AFINITOR (10 mg)

Everolimus

Cancer

$394M

2020

SILENOR

Doxepin Hydrochloride

Insomnia

$47M

2020

NOXAFIL

Posaconazole

Fungal infections

$25M

2020

DICLEGIS

Doxylamine Succinate; Pyridoxine Hydrochloride

Nausea and vomiting associated with pregnancy

$163M

2020

ZORTRESS

Everolimus

Prevent rejection of organ transplant

$146M

* Source: IPD Analytics, www.ipdanalytics.com, Accessed June 17, 2019

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require you to use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, contact a Cigna representative. Group medical and pharmacy plans are insured and/or administered by Cigna Health and Life Insurance Company or its affiliates. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. All pictures are used for illustrative purposes only. This website is not intended for residents of New Mexico.

© 2019 Cigna. All rights reserved